pioglitazone has been researched along with Carcinoma, Small Cell Lung in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "small vs." | 1.38 | Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer. ( Behrens, C; Bookout, AL; Gadzar, AF; Girard, L; Jeong, Y; Lee, W; Mangelsdorf, DJ; Minna, JD; Raso, G; Wistuba, II; Xie, Y, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, Y | 1 |
| Xie, Y | 1 |
| Lee, W | 1 |
| Bookout, AL | 1 |
| Girard, L | 1 |
| Raso, G | 1 |
| Behrens, C | 1 |
| Wistuba, II | 1 |
| Gadzar, AF | 1 |
| Minna, JD | 1 |
| Mangelsdorf, DJ | 1 |
1 other study available for pioglitazone and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Area Under Curve; Biomarkers, Tumor; Carcinoma | 2012 |